Domain and Rusnano sign $760m US-Russian healthcare investment tie-up
This article was originally published in Scrip
Executive Summary
Domain Associates, one of the largest US venture capital firms operating in the healthcare sector, and Rusnano, the Russian state-owned investor in high-tech industries, have come together in an investment partnership focused on US innovation and Russian manufacturing. The firms have agreed to invest about $760 million from their venture capital funds in about 20 US-based healthcare technology companies and in building a pharmaceutical and medical device manufacturing facility in Russia.